Profound Medical Corp
TSX:PRN
Profound Medical Corp
TSX:PRN
Price:
11.39 CAD
9%
Market Closed
Updated:
May 15, 2024
Profound Medical Corp
Selling, General & Administrative
|
Profound Medical Corp
Selling, General & Administrative Peer Comparison
Comparables:
NVCN
OPS
NSCI
TLT
MIR
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Selling, General & Administrative
-$18.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Neovasc Inc
TSX:NVCN
|
Selling, General & Administrative
-$18.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-17%
|
|
|
Opsens Inc
TSX:OPS
|
Selling, General & Administrative
-CA$29.2m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-24%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Selling, General & Administrative
-CA$15.2m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Selling, General & Administrative
-CA$2.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-5%
|
|
|
MedMira Inc
XTSX:MIR
|
Selling, General & Administrative
-CA$2.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
6%
|
See Also
What is Profound Medical Corp's Selling, General & Administrative?
Selling, General & Administrative
-18.6m
USD
-18.6m
USD
Based on the financial report for Dec 31, 2023, Profound Medical Corp's Selling, General & Administrative amounts to -18.6m USD.
What is Profound Medical Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-18%
-18%
Over the last year, the Selling, General & Administrative growth was -4%. The average annual Selling, General & Administrative growth rates for Profound Medical Corp have been -14% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
